Credit Agricole’s VolitionRx Ltd VNRX Stock Holding History

Credit Agricole’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200	Closed	-$2.87K	–	989
2023 Q4	$2.87K	Hold	200	–	–	﹤0.01%	872
2023 Q3	$2.76K	Hold	200	–	–	﹤0.01%	885
2023 Q2	$5.56K	Hold	200	–	–	﹤0.01%	640
2023 Q1	$7.64K	Hold	200	–	–	﹤0.01%	598
2022 Q4	$9.72K	Hold	200	–	–	﹤0.01%	624
2022 Q3	$5K	Hold	200	–	–	﹤0.01%	634
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	619
2022 Q1	$12K	Hold	200	–	–	﹤0.01%	624
2021 Q4	$13K	Hold	200	–	–	﹤0.01%	629
2021 Q3	$12K	Hold	200	–	–	﹤0.01%	612
2021 Q2	$13K	Hold	200	–	–	﹤0.01%	596
2021 Q1	$15K	Hold	200	–	–	﹤0.01%	552
2020 Q4	$16K	Hold	200	–	–	﹤0.01%	476
2020 Q3	$13K	Hold	200	–	–	﹤0.01%	443
2020 Q2	$16K	Hold	200	–	–	﹤0.01%	389
2020 Q1	$12K	Hold	200	–	–	﹤0.01%	405
2019 Q4	$19K	Hold	200	–	–	﹤0.01%	365
2019 Q3	$22K	Hold	200	–	–	﹤0.01%	416
2019 Q2	$13K	Hold	200	–	–	﹤0.01%	437
2019 Q1	$13K	Hold	200	–	–	﹤0.01%	433
2018 Q4	$7K	Hold	200	–	–	﹤0.01%	440
2018 Q3	$10K	Buy	+200	New	+$8.22K	﹤0.01%	408

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Credit Agricole's VNRX Position: Q1 2024 in Review

Credit Agricole sold out of VolitionRx Ltd (VNRX) in Q1 2024, closing a stake of 200 shares — an estimated $2.87K sold.

Credit Agricole first reported a position in VNRX in Q3 2018 and held it in 22 quarters. The position peaked at $22K in Q3 2019. 24 funds tracked by Wall St. Rank hold VNRX as of Q1 2024.

Credit Agricole reported no remaining VolitionRx Ltd position as of Q1 2024 after selling out during the quarter.
Credit Agricole sold 200 VolitionRx Ltd shares in Q1 2024, an estimated $2.87K.
Credit Agricole first reported a position in VolitionRx Ltd in Q3 2018 and held it in 22 quarters.
Credit Agricole's VolitionRx Ltd position peaked at $22K in Q3 2019.
24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2024.

Based on Credit Agricole's 13F filing for Q1 2024, filed 14 May 2024.